Departamento de Química Inorgánica y Analítica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Chile.
Bioorg Med Chem. 2009 Dec 15;17(24):8186-96. doi: 10.1016/j.bmc.2009.10.030. Epub 2009 Oct 20.
New 5-nitroindazole derivatives were developed and their antichagasic properties studied. Eight compounds (14-18, 20, 26 and 28) displayed remarkable in vitro activities against Trypanosoma cruzi (T. cruzi). Its unspecific cytotoxicity against macrophages was evaluated being not toxic at a concentration at least twice that of T. cruzi IC(50), for some derivatives. The electrochemical studies, parasite respiration studies and ESR experiment showed that 5-nitroindazole derivatives not be able to yield a redox cycling with molecular oxygen such as occurs with nifurtimox (Nfx). The study on the mechanism of action proves to be related to the production of reduced species of the nitro moiety similar to that observed with benznidazole.
开发了新型 5-硝基吲唑衍生物,并研究了它们的抗恰加斯病特性。八种化合物(14-18、20、26 和 28)对克氏锥虫(T. cruzi)表现出显著的体外活性。其对巨噬细胞的非特异性细胞毒性在至少两倍于 T. cruzi IC50 的浓度下没有表现出毒性,对于一些衍生物而言。电化学研究、寄生虫呼吸研究和 ESR 实验表明,5-硝基吲唑衍生物不能像硝呋替莫(Nfx)那样与分子氧发生氧化还原循环。作用机制的研究证明与硝基部分的还原物种的产生有关,类似于苯并咪唑所观察到的。